CAS 158861-67-7 Endocrine System Hormones 98% HPLC GHRP-2 Pralmorelin Reseach Peptide

Product Details:

Place of Origin:	Wuhan China
Brand Name:	vanz
Model Number:	powder

Payment & Shipping Terms:

Minimum Order Quantity:	1g
Price:	50-60 USD per Gram
Packaging Details:	bottle or bag
Delivery Time:	3-5 working days
Payment Terms:	T/T, Western Union, MoneyGram
Supply Ability:	5kg per month

Contact Now

Detailed Product Description

158861-67-7

NAME:

Pralmorelin

High Light:

human endocrine hormones

Endocrine System Drugs

Hot sale 98% HPLC GHRP-2 Pralmorelin CAS 158861-67-7 Reseach Peptide

Basic information

Sequence: H-D-Ala-D-2-Nal-Ala-Trp-D-Phe-Lys-NH2
Molecular formula: C45H55N9O6
Molar Mass: 817.9
CAS number: 158861-67-7
PubChem: CID 6918245
Synonyms: Growth Hormone Releasing Peptide-2; GHRP2; GHRP 2

Introduction

GHRP-2 (also known as KP 102 or Pralmorelin) is a synthetic hexapeptide Growth Hormone Releasing Peptide (GHRP), which acts on the hypothalamus and the pituitary gland to release growth hormone with a slight stimulator effect on Prolactin, ACTH and Cortisol levels. GHRP-2 is considered to be a true hGH secretagogue, meaning that it stimulates the body’s own secretion of hGH. Human Growth hormone has been shown in studies to promote lean body mass and reduce adiposity (fat). GHRP2 has demonstrated that it is very effective at stimulating GH production in research test subjects. It has a short half life with peak concentrations occurring around 15 minutes and not longer than 60 minutes after administration

Related Products

Product Name	CAS No.	Product Name	CAS No.
Sincalide	25126-32-3	Salcitonin	47931-85-1
Liraglutide	204656-20-2	Terlipressin	14636-12-5
Leuprorelin	74381-53-6	Histrelin	76712-82-8
Octreotide	79517-01-4	Ipamorelin	170851-70-4
Oxytocin	50-56-6	Melanotan II	121062-08-6
Teriparatide	52232-67-4	Sermorelin	86168-78-7
Alarelin	79561-22-1	Deslorelin	57773-65-6
Exenatide	141732-76-5	Bivalirudin	128270-60-0
Angiotensin	1407-47-2	CJC-1295	863288-34-0
Argipressin	113-79-1	GHRP-2	158861-67-7
Atosiban	90779-69-4	GHRP-6	87616-84-0
Cetrorelix	120287-85-6	Gonadorelin	33515-09-2
Desmopressin	16679-58-6	Met-Enkephaline	58569-55-4
Enfuvirtide	159519-65-0	PT141	189691-06-3
Eptifibatide	188627-80-7	Somatostatin	38916-34-6
Glucagon	16941-32-5	Tetracosactide	16960-16-0
GLP-1	106612-94-6	Thymopentin	69558-55-0
Lysipressin	50-57-7		62304-98-7
MGF-24		Triptorelin	57773-63-4
Nesiritide	114471-18-0	Vapreotide	103222-11-3
Pramlintide	196078-30-5	Lanreotide	108763-35-2
GLP-1(7-36)	107444-51-9	Ziconotide Acetate	107452-89-1

GHRP-2 has been studied extensively for its utility as a growth hormone secretagogue (GHS). Scientists have discovered that the Growth Hormone Releasing Peptide-2 increases the natural production of growth hormone (GH). In the early 90’s, one of the most famous studies was performed and later published in 1997 in the Journal of Endocrinology and Metabolism. This study further exemplifies the theory that growth hormone releasing peptides (including Ipamorelin and ghrp-6) could help hormone deficient adults and children. Ever since these major scientific studies, GHRP-2 has been widely produced. With other scientific labs confirming the results from their studies, GHRP-2 can in fact work for those who lack the ability to make adequate human growth hormone. Results however will differ with the use of GHRP-2 because species respond differently based on the pituitary somatotrophs and the differences in the subtypes of GHRP receptors. In the physiologic system, the actions are blocked by GRF receptors antagonist which acts through a different receptor to that employed by earlier GHRPs.